IDVSmall business
FSS (multiple-award IDV) 36F79721D0239TRAVERE THERAPEUTICS, INC.
Overview
Award facts
- Obligated on orders under this IDV
- $981.75K
- $981,748 across 43 orders
- Period of performance
- From Sep 15, 2021
- Modifications
- 15
- Latest action Mar 3, 2026
- Contract type
- FSS (multiple-award IDV)
- PIID 36F79721D0239
Description of requirement
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Dates and value
- Award date
- Signed on Aug 31, 2021
- Ordering period ends
- Sep 14, 2026
- Ceiling
- Shared program ceiling (all awardees of this multiple-award vehicle, not a per-awardee value): $14,970,593
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 3, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationSAN DIEGO, CA
UEIJUBZMHK84S36
CAGE code77HN5
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyTRAVERE THERAPEUTICS, INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)Manufacturer of goods
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Veterans Affairs
- NAC FEDERAL SUPPLY SCHEDULE (36F797)
- Funded by
- Department of Veterans Affairs
- NAC FEDERAL SUPPLY SCHEDULE (36F797)
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Fixed price with economic price adjustmentK
Solicitation and notices
- Solicitation ID
- MS-QS0A-03-R8(as reported)
- Solicitation date
- May 20, 2021
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
Transaction history
Modification history
- Base award
- Aug 31, 2021
- Latest action
- Mar 3, 2026 — Supplemental agreement (within scope)Modification P00015
- Latest substantive action
- Mar 3, 2026 — Supplemental agreement (within scope)Modification P00015
- Actions by type
- Base award1
- Supplemental agreement (within scope)15
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- FSSC
- Multiple or single award
- Multiple awardM
- Awarding agency code
- 3600
- Awarding sub-tier code
- 3600
- Contracting office code
- 36F797
- Transactions recorded under this award key
- 16
Funding
- Funding agency code
- 3600
- Funding sub-tier code
- 3600
- Funding office code
- 36F797